2-(6-bromo-4-oxoquinazolin-3-yl)-n-(4-propan-2-ylphenyl)acetamide (CHEM312317)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-29 14:12:38 UTC | ||||||||
| Update Date | 2026-08-29 14:12:38 UTC | ||||||||
| Accession Number | CHEM312317 | ||||||||
| Identification | |||||||||
| Common Name | 2-(6-bromo-4-oxoquinazolin-3-yl)-n-(4-propan-2-ylphenyl)acetamide | ||||||||
| Class | Small Molecule | ||||||||
| Description | 2-(6-bromo-4-oxoquinazolin-3-yl)-n-(4-propan-2-ylphenyl)acetamide is a compound with the formula C19H18BrN3O2. It has an average molecular weight of 400.30 g/mol. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C19H18BrN3O2 | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 399.058 g/mol | ||||||||
| CAS Registry Number | 853318-73-7 | ||||||||
| IUPAC Name | 2-(6-bromo-4-oxoquinazolin-3-yl)-n-(4-propan-2-ylphenyl)acetamide | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CC(C)C1=CC=C(C=C1)NC(=O)CN2C=NC3=C(C2=O)C=C(C=C3)Br | ||||||||
| InChI Identifier | InChI=1S/C19H18BrN3O2/c1-12(2)13-3-6-15(7-4-13)22-18(24)10-23-11-21-17-8-5-14(20)9-16(17)19(23)25/h3-9,11-12H,10H2,1-2H3,(H,22,24) | ||||||||
| InChI Key | QMOGGJWDZJLTFH-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
